LOOMIS SAYLES & CO L P – United Therapeutics Corporation Transaction History
LOOMIS SAYLES & CO L P portfolio value:
$42.60M
portfolio value
LOOMIS SAYLES & CO L P quarter portfolio value change:
-11.14%
quarter
United Therapeutics Corporation 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +22.70% | 37.64K shares | 3.52M | $209.38 | 203.46K |
| Q2 2022 | share | Increase | +138.07% | 96.16K shares | 26.57M | $235.64 | 165.82K |
| Q1 2022 | share | Decrease | -5.53% | -4.07K shares | -3.43M | $179.41 | 69.65K |
| Q4 2021 | share | Increase | +0.29% | 210 shares | 2.36M | $215.18 | 73.72K |
| Q3 2021 | share | Decrease | -2.94% | -2.22K shares | -20K | $184.58 | 73.51K |
| Q2 2021 | share | Decrease | -0.43% | -327 shares | 865K | $179.41 | 75.74K |
| Q1 2021 | share | Decrease | -6.96% | -5.69K shares | 314K | $167.27 | 76.07K |
| Q4 2020 | share | Decrease | -24.80% | -26.96K shares | 1.42M | $151.79 | 81.76K |
| Q3 2020 | share | Decrease | -2.23% | -2.48K shares | -2.47M | $101 | 108.73K |
| Q2 2020 | share | Decrease | -1.47% | -1.66K shares | 2.75M | $121 | 111.21K |
| Q1 2020 | share | Increase | +14.50% | 14.29K shares | 2.02M | $94.83 | 112.88K |
| Q4 2019 | share | Decrease | -0.78% | -778 shares | 759K | $88.08 | 98.58K |
| Q3 2019 | share | Increase | +32.47% | 24.35K shares | 2.06M | $79.75 | 99.36K |
| Q2 2019 | share | Increase | 0.00% | 75.01K shares | 5.85M | $78.06 | 75.01K |
| Q1 2018 | share | Decrease | -100.00% | -86 shares | -13K | $112.36 | 0 |
| Q4 2017 | share | Decrease | -37.68% | -52 shares | -3K | $147.95 | 86 |
| Q3 2017 | share | Decrease | -29.59% | -58 shares | -9K | $117.19 | 138 |
| Q2 2017 | share | Increase | 0.00% | 196 shares | 25K | $129.73 | 196 |
| Q2 2016 | share | Decrease | -100.00% | -77 shares | -9K | $105.92 | 0 |
| Q1 2016 | share | Decrease | -47.26% | -69 shares | -14K | $111.43 | 77 |